Impact Factor
3.63
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.79
848 total citations
h5-index
30
h5 depth signal
Cited share
74.8%
175 of 234
Total citations
848
Citation footprint
Metric signal
3.93
External metric anchor
Self-citation
1.4%
12 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
292
United States
105
Saudi Arabia
66
Brazil
66
Iran
63
Citing Fields of Research
Diabetes
820
Endocrinology & Metabolism
73
Phytochemicals
70
Wounds & Ulcers
68
Nutrition & Dietetics
63
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,502
Articles tracked across the journal lifetime
Indexed publication set
234
175 cited publications
Last 12 months
95
9.5 publications/month
Open access share
66.3%
63 OA publications in the last year
Leading citing country
India
292 citing publications
Leading citing field
Diabetes
820 citing publications
Latest tracked publication
1 November 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2005-
v1n1, Jan. 2005-
Research Focus & Classification
Indexed Subjects
Diabetes
Broad Categories
Endocrinology
Diabetes
MeSH Descriptors
Diabetes Mellitus
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/157339982209260506141308
Open DOI
Corrigendum to: Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review
In the originally published article titled “Modern-Day Therapeutics and Ongoing Clinical Trials against Type 2 Diabetes Mellitus: A Narrative Review”, published in “Current Diabetes Reviews”, Vol: 21, 2025 [1], certain phrases and expres...
02
DOI 10.2174/0115733998416898251230195238
Open DOI
Integrative Nanotechnology and Biomaterial Approaches for Targeted Diabetic Wound Regeneration
Recent advancements in drug delivery technologies, bioactive molecules, and biomaterial design have transformed the therapeutic landscape of diabetic wound management. Diabetic wounds remain a major clinical challenge due to persistent i...
03
DOI 10.2174/0115733998413217251206210451
Open DOI
Characteristic Correlation between Staphylococcal Isolates from Wounds and Nares of Diabetic Foot Patients Living in Erbil City, Iraq
Introduction: Foot ulcers are a common and serious complication in patients with diabetes mellitus. Nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) may serve as a reservoir for autoinfection. This study aimed to inve...
04
DOI 10.2174/0115733998451601260128044731
Open DOI
Potential Involvement of Fructosylated Human Insulin and Serological Evidence in Subclinical Autoimmune Activity in Type 2 Diabetes Mellitus
Introduction: Type 2 Diabetes Mellitus (T2DM) involves chronic inflammation and recurrent hyperglycemia, often linked to excessive fructose intake. Some patients develop autoantibodies, indicating immune dysfunction. Fructose promotes pr...
05
DOI 10.2174/0115733998408978251206123827
Open DOI
The Relationship between Diabetes Complications and the Intestinal Microbiota
Introduction: The increasing prevalence of diabetes mellitus (DM) has intensified research into its mechanisms and complications. Alterations in gut microbiota are considered an environmental factor influencing the onset, progression, an...
06
DOI 10.2174/0115733998411102251127094217
Open DOI
Targeting the Gut Microbiota in the Treatment of Type 2 Diabetes: Dietary Interventions, Microbial Preparations, and Fecal Transplantation
Type 2 diabetes mellitus (T2DM) is the most prevalent metabolic disease worldwide, characterized by hyperglycemia and insulin resistance (IR). Its escalating global prevalence and the associated morbidity and mortality render it a major ...
07
DOI 10.2174/0115733998418191251127053922
Open DOI
Chain Mediating Role of Illness Perception and Fear of Hypoglycemia in Impaired Hypoglycemic Awareness and Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
Introduction: Impaired hypoglycemic awareness (IAH) in type 2 diabetes mellitus (T2DM) is linked to mild cognitive impairment (MCI), but the underlying mechanisms are unclear. This study aimed to explore the chain mediating role of two p...
08
DOI 10.2174/0115733998505609261006104914
Open DOI
Gliflozin-Derived SGLT2 Inhibitors: Recent Advances and Future Perspectives in the Management of Type 2 Diabetes
Gliflozin derivatives, a class of Sodium-Glucose Cotransporter (SGLT) inhibitors, have emerged as effective antidiabetic agents offering notable cardiovascular and renal protection. This class of compounds inhibits glucose reabsorption i...
09
DOI 10.2174/0115733998495346261007070830
Open DOI
Chronotherapeutic and Circadian Rhythm-Based Strategies in Diabetes Management: A Critical Opinion Based on Evidences
Diabetes mellitus is one of the world’s leading health problems, and standard approaches to therapy do not take into consideration the impact of circadian misalignment on metabolic health. Chronobiological processes are involved in regul...
10
DOI 10.2174/0115733998484763260928100503
Open DOI
Harnessing Artificial Intelligence-driven Approaches in the Diagnosis and Management of Diabetes and Diabetes-Associated Complications
Diabetes mellitus is a global health issue with escalating metabolic dysfunction, clinical heterogeneity, and rising microvascular and macrovascular consequences. Traditional diabetes diagnosis, risk assessment, treatment selection, and ...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 2, no. 1 (Feb. 2006).
Print issues ceased with v.3 (2007)
Also issued online.